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Background: Poor reporting of medical trials has triggered the development of trial reporting standards within the
scientific community. In addition to a description of the proposed intervention, adequate information about the
trial setting and the group of health workers (cadre) delivering the intervention would allow a better understanding
of the generalizability of the trial findings, facilitate replication of trial interventions and assist with assessment of
trials for inclusion in systematic reviews. This study aims to determine the completeness of reporting for trial setting
and cadre among trials included in two Cochrane reviews on iron and folic acid supplementation for women
during pregnancy.
Methods: From the 81 trials included in the two Cochrane reviews, we extracted data on the trial setting, including
the facility type and geographic location, facility descriptors (i.e. level of care) and population descriptors
(i.e. socioeconomic status); and the cadre, including professional qualifications, training and supervision.
Results: Almost all studies reported the facility type and location (96%). However, only 68% included this
information in the “methods” section of the report. Facility descriptors and population descriptors were less
commonly reported (26% and 54% respectively). For 34% of the trials, we found some account of the type of
health worker that delivered the intervention. Only 4% of the trials reported any training procedures.
Conclusions: Currently, complete reporting of setting and health worker cadre in iron and folic acid
supplementation in pregnancy trials remains far from ideal, limiting assessments of the applicability of the trial
findings. Trialists and journals need to ensure that this information is included in trial reports by adhering to and
improving current reporting standards and by not making assumptions regarding readers’ knowledge of the
context and of the intervention delivery mechanism.Background
Inadequate reporting of interventions in clinical trials
limits the potential of health research to inform policy
making and practice [1]. Assessing generalizability and
critically appraising or understanding trial results, as well
as exploring heterogeneous results in systematic reviews
of trials, becomes a significant challenge when the inter-
vention is described poorly. Policy makers, clinicians and
program managers increasingly look to systematic reviews* Correspondence: rachel_harper@med.unc.edu
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reproduction in any medium, provided the orand evidence-based clinical guidelines to steer decisions
on health interventions [2,3]. However, to implement a
global guideline in a particular jurisdiction it is necessary
to recognize local needs, priorities, barriers and resources.
With the current status of trial reporting, authors retrieving
and summarizing the evidence, as well as decision makers
interpreting it, may have difficulty assessing whether an effi-
cacious intervention could be applied in their context. Im-
portantly, the effects of interventions may vary with health
system factors, such as setting and delivering cadre [4].
More complete descriptions of the contexts or settings in
which trials were implemented, and which health worker or
other cadres were involved, are therefore essential [5-7].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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also necessary for reproducing the interventions in further
trials and for the critical evaluation of trial results when
conducting systematic reviews [8].
Guidelines such as the Consolidated Standards of
Reporting Trials (CONSORT) and Transparent Reporting
of Evaluations with Nonrandomized Designs (TREND)
have been developed to facilitate more complete reporting
of trials [9,10]. The CONSORT statement specifically rec-
ommends reporting of setting and intervention ‘with suffi-
cient details to allow replication’. For trials intending to
guide care decisions, the CONSORT extension for prag-
matic trials suggests describing the population, health
worker cadre and healthcare facility so as to account for
variability in results due to these aspects of a trial [11].
Previous studies have investigated the extent to which
these variables are reliably included in trial reports. There
have been recent indications of improvement in this area,
especially in the decade since the release of the CON-
SORT statement, but reporting is still not optimal [12].Objective
To determine the completeness of reporting for trial set-
ting and cadre among trials included in two Cochrane
reviews of iron and folic acid supplementation for
women during pregnancy.Methods
We assessed all trials included in two Cochrane reviews
that evaluated the effectiveness of iron and folic acid or
other micronutrient supplementation for women during
pregnancy. One review [13] evaluated the benefits and
harms of daily intervention with iron and folic acid,
while the other [14] assessed the benefits and harms of
intermittent supplementation. These reviews were se-
lected because they are typical of reviews of nutritional
interventions in public health and because they were to
be used in the development of a global evidence-
informed guideline. We contacted the review authors for
access to their trial repository, and collected the full-textTable 1 Trial reporting criteria investigated and numbers of t
Criteria investigated Descriptive points
Setting Type of facility (for example, primary care clinic) and
Details to help clarify the setting (for example, inform
services provided, whether privately or publicly fund
Description of the population receiving the interven
socioeconomic status, educational level, marital statu
Health worker cadre Level of training (professional qualifications, non-pro
Intervention-specific training received by health wor
Information regarding supporting cadres or supervisversions of each published or unpublished trial report,
including additional communications with the trial au-
thors. Relevant sections of trial reports published in lan-
guages other than English were translated.
We designed a spreadsheet to evaluate each trial report
based on its descriptions of setting and health worker cadre
(Table 1). One author (RH) reviewed the full text of each
report and of associated studies if cited, and extracted infor-
mation relating to the setting - (including type of healthcare
facility and its geographic location, and additional descrip-
tive details of the facility and the population) - and informa-
tion about the health worker cadre who delivered the
intervention - (including level of training, any intervention-
specific training, and the presence of supporting cadres or
supervision). These criteria were based on sections 4 and 5
of the 2010 CONSORT statement, which gives a minimum
set of recommendations for the reporting of trial partici-
pants and interventions [9]. Information was extracted
from any section of the reports, noting when setting or
cadre descriptions were located outside of the methods sec-
tion. Incomplete descriptions, such as geographic location
(for example, Toronto, Canada) without type of facility (for
example, tertiary care hospital), or those that had to be
inferred from sections of the text outside of the methods
section, were not included in counts of satisfactory
reporting. To ensure reliability, another author (SL)
reviewed ten trials selected at random, and any discrepan-
cies and irregularities in reporting were discussed with the
other authors. We used simple descriptive statistics to
summarize the results (Additional file 1).Results
We evaluated reports for 68 of the 81 included trials.
Three trials were unpublished with only abstracts or raw
data available, and had no written description of the inter-
vention. Ten reports were subsequent publications of the
included trials and were grouped with the original publica-
tion for the purpose of this evaluation (Additional file 2).
The papers were published between 1947 and 2009, with
the majority of papers in the last 25 years. Table 1 presents
a summary of the results.rials with satisfactory reporting
Trials reporting
geographic location (for example, Mexico City) 68% (n = 46/68)
ation on care level, types of
ed, characteristics of supervisory or management staff)
26% (n = 18/68)
tion (for example,
s et cetera)
54% (n = 37/68)
fessional training or experience) 34% (n = 23/68)
kers involved in delivery of the intervention 4% (n = 3/68)
ion 25% (n = 17/68)
Harper et al. Systematic Reviews 2013, 2:42 Page 3 of 4
http://www.systematicreviewsjournal.com/content/2/1/42Setting and population
Ninety-six percent of the trials (n = 65/68) reported the
type of healthcare facility and its geographic location.
No other variable was reported as frequently, and many
studies reported only these descriptive points. This in-
formation was reported in the methods section of the
paper in only 68% of the papers (n = 46/65). Often this
information had to be deduced from the byline, intro-
duction, background or acknowledgments sections of
the paper.
Twenty-six percent (n = 18/68) of the reports included
additional detail about the facility (for example, informa-
tion on care level, types of services provided, whether
privately or publicly funded, characteristics of supervis-
ory or management staff ). Fifty-four percent (n = 37/68)
commented on the socioeconomic characteristics of the
participants.
Cadre
Forty-three percent (n = 29/68) of the reports included
some information about the health worker cadre delivering
the intervention. Of these, twenty-three reports explicitly
mentioned the cadre, while in the remaining six reports the
delivering cadre could be reasonably deduced from other
details in the report. Information about the training of
primary and supporting cadres was included among 4%
(n = 3/68) and 3% (n = 2/68) of the trials, respectively.
Discussion
The reporting of setting and health worker cadre in the
trials evaluated in this study was generally poor. Often,
these intervention components were not stated explicitly
in the methods section and had to be searched for, or de-
duced. This is surprising considering that numerous re-
sources are now available for researchers designing,
conducting and reporting randomized trials. For example,
the CONSORT statement and checklist have been im-
proved and extended to include abstracts, traditional
Chinese medicine, sports injury treatment and pragmatic
trials, among other topics. Specifically, the pragmatic trial
amendment to the CONSORT Statement – the section
applicable to many of the trials included in this study –
discusses setting and care provider descriptions as a part
of Methods and Generalizability [11]. The same is true
for the TREND guidelines for the reporting of non-
randomized behavioral and public health interventions.
Although many of the trials we examined were published
before initiatives such as CONSORT, problems of re-
porting were seen across all of the trials regardless of pub-
lication date. Inadequate guidance is therefore probably
not the main cause of the poor reporting seen here. Other
methodological studies suggest that trial reporting is
improving but also indicate that it remains far from
adequate [15,16].In a published trial report, both authors and journal
editors share responsibility for ensuring the quality of
reporting. There is some evidence that despite their sup-
port for reporting standards, journal editors and referees
do not always adequately screen articles before publica-
tion [16,17]. Moreover, authors who try to follow the
guidelines may be constrained by journal word count
limitations. More recently, strategies that allow authors
additional space for reporting intervention details have
been made possible by electronic publication [1]. How-
ever, for the level of reporting to improve, it is crucial
that both editors and authors recognize the assumptions
that readers may be making; for example, a researcher in
the United Kingdom may have a very different concept
of a maternity ward to a policy maker in Nigeria. Cur-
rently, information necessary to inform judgments re-
garding the applicability of an intervention is absent
from many study reports [18].
Direct contact with trial authors is another source for
extended information about a trial, but this is a prob-
lematic one. Although no data were gathered from au-
thors for this report, the researchers did attempt to
contact authors of the trials included in the reviews as
part of a larger study. Email addresses or phone num-
bers were difficult to find for all researchers and some of
the primary and secondary authors were deceased or no
longer in the field. Of the authors whom we were able to
contact, a majority did not respond to our emails. This
is therefore not an adequate, long-term solution.
Rather than adjusting current standards for reporting,
such as CONSORT and TREND, perhaps we need to re-
visit what is understood by ‘an intervention’. In this study,
the importance given to the reporting of wider health sys-
tem elements related to setting and care provider appeared
to be low, despite these being essential to interpreting the
outcomes and assessing the generalizability of a study. This
may be because trial authors regard the technical aspects
of interventions - such as the dose, formula, time-scale,
and delivery method of micronutrient supplements - as el-
ements of the intervention that deserve description [13,14].
However, we would argue that wider health systems ele-
ments should be consistently considered and reported by
researchers so as to inform judgments about whether and
how to implement interventions within a health system.
Conclusions
This study confirms that some elements of trial reporting
in the field of public health nutrition are not complete.
Authors frequently include the geographic location of a
trial, but fail to supply setting and cadre details necessary
for the application of study findings. Strategies to increase
the opportunities within medical journal publications for
authors to provide detailed intervention descriptions, for
example, through the inclusion of electronic appendices
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mote poor reporting. Better reporting will, in turn, fa-
cilitate assessments of the applicability of trial findings
and contribute to more appropriate implementation of
interventions within health systems [1,19]. Improved
reporting is also an ethical imperative, given that many
trials are publicly funded.
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